Related Experiment Video
Updated: Aug 2, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.3K
Corrigendum: A progression analysis of motor features in Parkinson's disease based on the mapper algorithm
Ling-Yan Ma1,2, Tao Feng1,2,3, Chengzhang He4
1Department of Neurology, Center for Movement Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Frontiers in Aging Neuroscience
|April 20, 2023
Summary
This study investigates the role of the gut microbiome in Alzheimer's disease progression. Findings suggest specific bacterial species influence amyloid-beta deposition and neuroinflammation.
Area of Science:
- Neuroscience
- Microbiology
- Immunology
Context:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta plaques and neuroinflammation.
- The gut microbiome's influence on brain health and disease is an emerging area of research.
- Alterations in gut microbiota composition have been observed in individuals with AD.
Purpose:
- To investigate the causal relationship between specific gut bacteria and Alzheimer's disease pathology.
- To explore the mechanisms by which gut microbes may modulate neuroinflammation and amyloid-beta aggregation.
Summary:
- This study utilized mouse models to demonstrate that certain gut bacterial species can exacerbate Alzheimer's disease hallmarks.
- Specific microbial metabolites were identified as potential mediators of neuroinflammation and amyloid-beta accumulation.
- Transplantation of specific gut microbiota altered disease severity in recipient mice.
Impact:
- Provides novel insights into the gut-brain axis in Alzheimer's disease.
- Identifies potential microbial biomarkers for AD risk and progression.
- Suggests therapeutic strategies targeting the gut microbiome for AD prevention or treatment.
